SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-22-004652
Filing Date
2022-03-02
Accepted
2022-03-02 14:29:27
Documents
21

Document Format Files

Seq Description Document Type Size
1 424B3 nautilusmarch2022424b3.htm 424B3 1884286
2 business10a.jpg GRAPHIC 45011
3 business11a.jpg GRAPHIC 97071
4 business12a.jpg GRAPHIC 92686
5 business13a.jpg GRAPHIC 19977
6 business14a_higherres.jpg GRAPHIC 126410
7 business15a.jpg GRAPHIC 109911
8 business16a.jpg GRAPHIC 39343
9 business17a.jpg GRAPHIC 33046
10 business1a.jpg GRAPHIC 131188
11 business2a.jpg GRAPHIC 110086
12 business3a.jpg GRAPHIC 117780
13 business4a.jpg GRAPHIC 88581
14 business5a.jpg GRAPHIC 67439
15 business6a.jpg GRAPHIC 127790
16 business7a.jpg GRAPHIC 196912
17 business8a.jpg GRAPHIC 144608
18 business9a.jpg GRAPHIC 24808
19 humanproteomecoverageacros.jpg GRAPHIC 99399
20 nautiluslogo.jpg GRAPHIC 106309
21 phasesleadingtocommerciall.jpg GRAPHIC 200665
  Complete submission text file 0001628280-22-004652.txt   4600608
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258100 | Film No.: 22702746
SIC: 3826 Laboratory Analytical Instruments